Achondroplasia is due to activating mutations in the Fibroblast Growth Factor Receptor 3 gene (FGFR3), consisting in a glycine-to-arginine substitution in the transmembrane domain of the receptor (position 380) in more than 97% of cases [5, 6]. This evidence concerns the gene FGFR3 and achondroplasia.